2025
JUNE
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 6
424
IMPACT OF VITAMIN D DEFICIENCY ON THE CLINICAL COURSE OF
MENOPAUSE: A CLINICAL AND BIOCHEMICAL CORRELATION STUDY
Zufarova Shahnoza Alimjanovna
Professor, Department of Obstetrics and Gynecology, Pediatric Gynecology, Tashkent Pediatric
Medical Institute.
ORCID: 0000-0003-0966-9694.
Email:
Shahnoza1970@yandex.ru
Amonova Madina Furkatovna
Assistant, Department of Obstetrics and Gynecology No. 3, Samarkand State Medical University
https://doi.org/10.5281/zenodo.15731321
Relevance
:
Menopause is a critical physiological transition in women, often accompanied by diverse
and sometimes severe symptoms. Recent studies highlight that vitamin D deficiency
—
commonly
found in postmenopausal women
—
may aggravate both physical and psychological manifestations
of menopause, including hot flashes, bone pain, mood disturbances, and fatigue. The relationship
between hypovitaminosis D and menopause remains insufficiently explored in Central Asian
populations. The transition into menopause represents a profound physiological and
endocrinological shift in a woman’s life, often accompanied by an array of uncomfortable and
sometimes debilitating symptoms that can significantly impair daily functioning and overall well-
being. With global demographic trends showing an increasing number of women entering
postmenopausal age, understanding the factors that influence the severity of menopausal
symptoms has become an urgent public health priority. One such factor is vitamin D deficiency,
which is alarmingly prevalent among middle-aged and older women due to reduced sun exposure,
dietary inadequacies, and impaired skin synthesis. This micronutrient is not only vital for
maintaining bone integrity but also plays an emerging role in neuroendocrine regulation and
immune modulation. Deficiency of vitamin D may contribute to heightened vasomotor instability,
increased risk of osteoporosis, mood fluctuations, and chronic fatigue, thereby intensifying the
challenges faced during menopause. Despite its potential impact, the connection between vitamin
D insufficiency and menopause-related symptomatology remains under-investigated, particularly
in Central Asian populations. This study seeks to address this gap and offer insights that can refine
therapeutic guidelines and prevent
ive strategies for women’s health during the menopausal
transition.
Objective
:
To investigate the impact of vitamin D deficiency on the severity and profile of menopausal
symptoms and to determine whether vitamin D status can serve as a prognostic marker in
menopausal management. This study aims to conduct a comprehensive analysis of how
insufficient levels of vitamin D affect the course of menopause, with a specific focus on the
severity and variety of clinical manifestations observed during this period. The purpose is to
explore whether a deficiency in this essential fat-soluble vitamin exacerbates neurovegetative,
musculoskeletal, and psycho-emotional symptoms commonly experienced by menopausal
women. Another important goal is to determine the possible predictive value of serum 25-
hydroxyvitamin D concentrations in identifying individuals at higher risk for intensified
2025
JUNE
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 6
425
menopausal complaints and early bone metabolism disturbances. Furthermore, the investigation
intends to contribute practical evidence that may inform the inclusion of vitamin D screening and
supplementation in gynecological protocols for menopausal health management. By establishing
a correlation between biochemical markers and clinical symptoms, the study hopes to provide a
foundation for personalized treatment strategies aimed at alleviating the burden of menopause in
women with compromised vitamin D status.
Materials and Methods:
A total of 120 postmenopausal women aged 45
–
60 were enrolled and divided into two
groups based on serum 25(OH)D levels: deficient (<20 ng/mL) and sufficient (>30 ng/mL).
Standardized scales including the Menopause Rating Scale (MRS) and Beck Depression Inventory
(BDI) were used to assess symptom severity. Bone mineral density was measured using DEXA
scanning. Statistical correlations were analyzed using SPSS 26.0 software.
Findings
:
Vitamin D deficiency was present in 68.3% of participants and was significantly associated
with higher scores for vasomotor instability, musculoskeletal pain, mood disorders, and poor sleep
quality. A strong inverse relationship was found between serum vitamin D levels and overall
symptom burden (r = -0.61, p < 0.01). Bone mineral density was also significantly lower in the
deficient group, indicating early osteopenic changes.
Conclusion
:
Vitamin D plays a crucial modulatory role in the menopausal transition. Women with low
vitamin D levels are more likely to experience intense menopausal symptoms and early skeletal
complications. Routine screening and correction of vitamin D deficiency may enhance therapeutic
outcomes and improve the quality of life for menopausal women. The findings of this study
underscore the critical influence of vitamin D status on the clinical expression of menopausal
symptoms. Women with insufficient or deficient levels of vitamin D were shown to experience
more severe and diverse manifestations, including increased frequency and intensity of vasomotor
symptoms such as hot flashes and night sweats, as well as pronounced musculoskeletal discomfort,
depressive mood states, and general fatigue. Additionally, lower serum vitamin D concentrations
were associated with early signs of bone demineralization, suggesting a potential acceleration of
osteoporotic changes during the menopausal transition. These results highlight the importance of
recognizing vitamin D not only as a skeletal health regulator but also as a key factor modulating
the neuroendocrine and psychological components of menopause. Considering the widespread
prevalence of vitamin D deficiency in perimenopausal and postmenopausal women, particularly
in regions with limited sun exposure or cultural practices that reduce sunlight absorption, there is
a compelling need to incorporate routine screening for vitamin D status into gynecological care
protocols. Furthermore, timely correction of this deficiency through dietary adjustment,
supplementation, or lifestyle modifications may serve as a simple yet effective strategy to alleviate
menopausal complaints, enhance quality of life, and prevent long-term complications such as
osteoporosis and mood disorders. This study supports a more integrated approach to menopausal
healthcare, advocating for the inclusion of micronutrient evaluation as part of personalized
treatment and preventive care strategies.
2025
JUNE
NEW RENAISSANCE
INTERNATIONAL SCIENTIFIC AND PRACTICAL CONFERENCE
VOLUME 2
|
ISSUE 6
426
REFERENCES
1.
Holick MF. Vitamin D deficiency. New England Journal of Medicine. 2007;357(3):266
–
281.
2.
Pal L, Woods NF. Role of vitamin D in the aging female reproductive system. Menopause.
2013;20(5):456
–
464.
3.
Lerchbaum E, Obermayer-Pietsch B. Vitamin D and fertility: a systematic review.
European Journal of Endocrinology. 2012;166(5):765
–
778.
4.
Zhao Y, Tao M, Chen L. Effects of vitamin D supplementation on bone mineral density
and menopausal symptoms in postmenopausal women. Climacteric. 2018;21(3):280
–
285.
5.
Saad F, Haider A, Doros G. Hypovitaminosis D and its association with menopausal
symptomatology: a clinical overview. Journal of Steroid Biochemistry and Molecular
Biology. 2019;189:211
–
215.
6.
Shirazi L, Almquist M, Hallmans G, et al. Serum 25-hydroxyvitamin D levels and
menopausal complaints: a longitudinal analysis. Maturitas. 2020;138:42
–
48.
7.
Gallagher JC. Vitamin D and aging. Endocrinology and Metabolism Clinics.
2013;42(2):319
–
332.
8.
Pludowski P, Holick MF, Pilz S, et al. Vitamin D effects on musculoskeletal health,
immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, and
mortality
—
a review of recent evidence. Autoimmunity Reviews. 2013;12(10):976
–
989.
9.
Kuchuk NO, van Schoor NM, Pluijm SM, et al. Vitamin D status, parathyroid function,
bone turnover, and BMD in postmenopausal women with vitamin D insufficiency.
Osteoporosis International. 2009;20(3):479
–
487.
10.
Karras SN, Anagnostis P, Bili E, et al. Maternal vitamin D levels during pregnancy and
postpartum depression: a systematic review. European Journal of Obstetrics & Gynecology
and Reproductive Biology. 2014;179:17
–
24.
